Ease of travel, interconnected financial markets, and differences in testing & response have upped the collateral damage from this latest coronavirus.
Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.
Noted public health expert Dr. William Schaffner shares insights on three of his top public health threats.
Dentists, dental hygienists, pediatricians, family practitioners and other primary care providers play an important role in the early detection of oral cavity cancers, and ... equally importantly ... in fostering prevention by providing education on key risk factors.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: